Samsung Biologics to join carbon neutral initiative

By The Science Advisory Board staff writers

September 13, 2021 -- Contract development and manufacturing organization Samsung Biologics has signed a memorandum of understanding to join the Frontier 1.5D initiative, which will develop a climate risk management model as part of South Korea's 2050 Carbon Neutral Strategy.

Samsung Biologics has joined the Frontier 1.5D Project as part of the 2050 Carbon Neutral Initiative. Image courtesy of Samsung Biologics.

Frontier 1.5D is an effort to limit global temperature rise to 1.5 degrees Celsius above preindustrial levels. Samsung plans to monitor its biopharmaceutical manufacturing plants through an initiative it calls the Carbon Disclosure Project, the company said.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.